UNII W4888I119H

TARTARIC ACID

Unique Ingredient Identifier W4888I119H is listed as a ingredient substance
RN87-69-4
EC201-766-0
NCITC47744
RXCUI37578
PUBCHEM444305
MFC4H6O6
INCHI KEYFEWJPZIEWOKRBE-JCYAYHJZSA-N
SMILESO[C@H]([C@@H](O)C(O)=O)C(O)=O

Alternate Names

Dosage Forms

UNII W4888I119H TARTARIC ACID is commonly included in medications in the following forms.

RouteDosage FormPotency
INTRAMUSCULARINJECTION0.35 %
INTRAMUSCULARPOWDER, FOR INJECTION SOLUTION, LYOPHILIZED0.35 %
INTRAMUSCULARSOLUTION, INJECTION0.23 %W/V
INTRAVENOUSINJECTABLE0.5 %
INTRAVENOUSINJECTION2 %
INTRAVENOUSINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION2 %
INTRAVENOUSPOWDER, FOR INJECTION SOLUTION, LYOPHILIZED2 %
INTRAVENOUSSOLUTION, CONCENTRATE0.5 %
INTRAVENOUSSOLUTION, INJECTION20 MG/4ML
INTRAVENOUSSOLUTION, INJECTION0.23 %
IV(INFUSION)INJECTION2 %
IV(INFUSION)POWDER, FOR INJECTION SOLUTION, LYOPHILIZED2 %
ORALCAPSULE230 mg
ORALCAPSULE, EXTENDED RELEASE260 MG
ORALCAPSULE, SUSTAINED ACTION215.1 MG
ORALPOWDER, FOR SOLUTION15 MG/1ML
ORALSOLUTION0.75 %W/W
ORALSUSPENSION10 MG/5ML
ORALTABLET40 MG
ORALTABLET, COATED10 MG
ORALTABLET, EXTENDED RELEASE75 MG
ORALTABLET, FILM COATED30 MG
ORALTABLET, FOR SUSPENSION7 MG
ORALTABLET, ORALLY DISINTEGRATING45 MG
ORALTABLET, SUSTAINED ACTION29.2 MG
RECTALSUPPOSITORY21.5 MG
SUBCUTANEOUSSOLUTION, INJECTION0.23 %
SUBLINGUALTABLET1.5 MG
TOPICALFILM, CONTROLLED RELEASE ADJPH
TOPICALPATCH67 MG
TOPICALPATCH, CONTROLLED RELEASE NA

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.